Soleus Capital Management, L.P. Ideaya Biosciences, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.18 Billion
- Q3 2024
A detailed history of Soleus Capital Management, L.P. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 1,049,314 shares of IDYA stock, worth $28.1 Million. This represents 2.82% of its overall portfolio holdings.
Number of Shares
1,049,314
Previous 694,069
51.18%
Holding current value
$28.1 Million
Previous $24.4 Million
36.42%
% of portfolio
2.82%
Previous 2.47%
Shares
4 transactions
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$182 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$140 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$138 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$128 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$108 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.29B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...